Izotropic CEO Interview - Prototype REVEAL SOON! (CSE:IZO)

November 2, 2022

Justin Interviews Izotropic Corporation CEO Dr. John McGraw! John joins the show to discuss how IzoView prototype is approximately four weeks from completion, and the benefits of finalizing the move to the United States!

Izoview Final Engineering Showcasing -
Izotropic finalizes engineering and U.S transition -

Izotropic Corporation is the only publicly-traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers.IzoView produces high resolution breast images in true 3D with low radiation dose levels,and is ideal for imaging patients with dense breast tissue.